AmrikachiM, RamzyI, RubenfeldS, et al.Accuracy of fine-needle aspiration of thyroid. Arch Pathol Lab Med, 2001; 125(4):484–488; doi: 10.5858/2001-125-0484-AOFNAO.
2.
McCoyKL, JabbourN, OgilvieJB, et al.The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery, 2007; 142(6):837–844; doi: 10.1016/j.surg.2007.08.012.
3.
BaserOO, KoseogluD, CetinZ, et al.Benign cytology does not rule out malignancy in thyroid nodules larger than 4 cm. Diagn Cytopathol, 2022; 50(11):508–512; doi: 10.1002/dc.25024.
4.
CiprianiNA, WhiteMG, AngelosP, et al.Large cytologically benign thyroid nodules do not have high rates of malignancy or false-negative rates and clinical observation should be considered: A meta-analysis. Thyroid, 2018; 28(12):1595–1608; doi: 10.1089/thy.2018.0221.
5.
Steinmetz-WoodSN, KennedyAG, TompkinsBJ, et al.Navigating the debate on managing large (≥4 cm) thyroid nodules. Int J Endocrinol, 2022; 2022(1):6246150; doi: 10.1155/2022/6246150.
6.
Albuja-CruzMB, GoldfarbM, GondekSS, et al.Reliability of fine-needle aspiration for thyroid nodules greater than or equal to 4 cm. J Surg Res, 2013; 181(1):6–10; doi: 10.1016/j.jss.2012.06.030.
7.
SwaminathanN, LaboyAJ, IzharA, et al.Malignancy risk and diagnostic accuracy of fine-needle aspiration in thyroid nodules ≥4 cm: A retrospective analysis of incidental cancer. Am Surg. Epub, 2025; doi: 10.1177/00031348251407348.
